Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Providers
Hospitals
Practices
Retail
Health Tech
AI and Machine Learning
Digital Health
Telehealth
Payers
Regulatory
Finance
Special Reports
Fierce 50
Special Report
Awards Gala
Awards
DEI Awards
Innovation Awards
Resources
Webinars
Fierce Events
Industry Events
Podcasts
Survey
Whitepapers
Events
Subscribe
Subscribe
Providers
Hospitals
Practices
Retail
Health Tech
AI and Machine Learning
Digital Health
Telehealth
Payers
Regulatory
Finance
Special Reports
Fierce 50
Special Report
Awards Gala
Awards
DEI Awards
Innovation Awards
Resources
Webinars
Fierce Events
Industry Events
Podcasts
Survey
Whitepapers
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
controlled substance
Regulatory
DEA allows another year of telehealth prescribing flexibilities
The fourth temporary extension continues the status quo of controlled substance prescribing via telehealth since 2020.
Emma Beavins
Dec 31, 2025 11:10am
Done indicted on alleged $100M illegal Adderall scheme
Dec 19, 2025 6:30pm
ADHD startup founder convicted in Adderall fraud scheme
Nov 20, 2025 3:15pm
DEA to publish 4th extension of telehealth prescribing rule
Nov 13, 2025 4:15pm
DEA, HHS delay effective date of virtual OUD prescribing rule
Feb 18, 2025 2:15pm
Top policy issues for hospitals, payers, docs and tech in 2025
Feb 12, 2025 6:00am
